Document is current
Any future updates will be listed below
-
Authors
Higuchi, Tae
Ide, Tomomi
Fujino, Takeo
Tohyama, Takeshi
Nagatomi, Yuta
Nezu, Tomoyuki
Ikeda, Masataka
Hashimoto, Toru
Matsushima, Shouji
Shinohara, Keisuke
Nishihara, Masaaki
Iyonaga, Takeshi
Akahoshi, Tomohiko
Ushijima, Tomoki
Shiose, Akira
Kinugawa, Shintaro
Tsutsui, Hiroyuki
Abe, Kohtaro
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP22K08103, JP24K22274)
Japan Research Foundation for Clinical Pharmacology
- License Information
-
More Information
Article History
Received: 24 August 2024
Accepted: 20 January 2025
First Online: 28 January 2025
Declarations
:
: Takeo Fujino is a member of the endowment department supported by NIPRO, Medtronic Japan and Abbott Medical Japan. The other authors declare no competing interests.
: It was conducted in accordance with the Declaration of Helsinki, and we obtained written informed consent after fully explaining the study, risks, and freedom to participate to patients or their families. We obtained the approval of the Ethics Review Committee for Clinical Research of the Kyushu University Medical School District Department (license number: 2019–585, approval date: 2019-2-24, study title: A Study of ICU-AW Occurrence and Improvement of Exercise Capacity in Critical Cardiac Disease).
